asset currency, searches

Pinduoduo stocks fell more than 3% before trading.UN Secretary-General Guterres: I fully believe that the Syrian people can choose their own destiny.CPOPC: The price of palm oil is expected to fluctuate in the range of RM 4,000-5,000 in 2025. It is reported that the Council of Palm Oil Producers (CPOPC) predicts that the price of palm oil may fluctuate in the range of RM 4,000-5,000 per ton in 2025, driven by the stagnant production in major markets, especially Indonesia and Malaysia. Deputy Secretary-General CPOPC pointed out that the current price level around RM5,000 per ton may be temporary, mainly affected by the continuous floods in Malaysia, which boosted the bullish sentiment in the market. Due to the aging plantations, unpredictable weather and limited expansion to new plantations, it is expected that the cessation of production will tighten global supply and further push up prices.

France urges Israel to withdraw from the Syrian buffer zone.France urges Israel to withdraw from the Syrian buffer zone.The USD/JPY intraday increase of USD/JPY expanded to 0.50% and is now reported at 152.72.

Macy's fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors.Putin had a phone conversation with Hungarian President Orban on the situation in Ukraine.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)